key: cord-0802635-zwzngwb8
authors: Montgomery, Hugh; Rehill, Niran; Camporota, Luigi; Credland, Nicki; Grocott, Mike; Hamilton, Mark; Martin, Daniel; Patel, Brijesh; Suntharalingam, Ganesh; Szakmany, Tamas; Uddin, Shahana; Vercueil, Andre; Roberts, Mike
title: COVID-19: UK frontline intensivists' emerging learning
date: 2020-06-12
journal: J Intensive Care Soc
DOI: 10.1177/1751143720931731
sha: 37ebfd41ed8b14f8b40078db902432b78c445650
doc_id: 802635
cord_uid: zwzngwb8

The Intensive Care Society held a webinar on 3 April 2020 at which representatives from 11 of the most COVID-19 experienced hospital trusts in England and Wales shared learning around five specific topic areas in an open forum. This paper summarises the emerging learning and practice shared by those frontline clinicians.

This is NOT a clinical guideline. The suggestions for practice outlined represent professional opinion only.

At the time of writing, 51,608 people have tested positive for COVID-19 in the UK in less than three months; 5373 have died. 1 These figures will have risen by the time you read this. Around 5% 2 of COVID-19 infections appear to require intensive care unit (ICU) admission. As the number of people contracting the illness increases rapidly, so does ICU clinical experience. Hundreds of intensivists will by now have had to manage multiple complex COVID-19 patients.

A variety of guidelines have been rapidly produced (e.g. NICE guidance on critical care escalation, 3 Surviving Sepsis guidelines 4 and more), and NHS England with the Faculty of Intensive Care Medicine plan release of UK management guidelines shortly. However, solid data upon which to base these are sparse. As a result, optimal management depends on rapid dissemination of experiential learning.

To address this need, the Intensive Care Society held a webinar on 3 April 2020 at which representatives from 11 of the most COVID-19 experienced hospital trusts in England and Wales shared learning around five specific topic areas in an open forum. This paper summarises the emerging learning and practice shared by those frontline clinicians. It represents their professional opinions at the time and should not be used as a clinical guideline document. Key emerging knowledge and suggestions for practice are presented in bold. Bullets in italics outline modifications to clinical practice made by individual trusts. Re-intubation rates within 24-48 h seem higher than expected (up to 60%) so delaying initial extubation for longer than usual may be sensible.

Waiting 48 h past fever resolution and monitoring the inflammatory markers to ensure hyperinflammatory state is improving before attempted extubation

. Antibiotic usage should be judicious. There are some reports of later aspergillosis and candida infections.

Examples of clinical practice: Stopping antibiotics in COVID patients unless clearly indicated, using procalcitonin (PCT) and other inflammatory markers to monitor for bacterial infection and restarting as required* Using procalcitonin as a 'stop' signal to guide when to stop antibiotic use* *False negative PCTs seem less of an issue than false positives in determining antibiotic useanecdotally, rising procalcitonin has been seen in patients without evidence of bacterial infection, perhaps in relation to 'cytokine storm', and so a low PCT may be more helpful (true negative) than a high PCT (false positive) 4. Fluid balance and renal support . Profound pyrexia, followed by use of CPAP, may mean that patients are dehydrated. . Careful use of fluids aiming for euvolaemia may be beneficial in early phase disease -provided that the ventilation effort is well controlled to avoid oedema -as perfusion is a problem and prior to intensive care patients tend to have been dry. . Renal injury has been more common in UK cases than anticipated (20-35% of ICU patients 

COVID-19 dashboard

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China

COVID-19 rapid guideline: critical care in adults. NICE 2020 (NICE guideline

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

COVID-19 pneumonia: different respiratory treatment for different phenotypes?

With thanks to Dr Sandy Mather and the Intensive Care Society for hosting the webinar, Dr Amanda Begley and Morgan McKean, UCL Partners, for coordinating and supporting the rapid synthesis of findings and Professor Rosalind Raine, NIHR ARC North Thames for reviewing an early draft.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author(s) received no financial support for the research, authorship, and/or publication of this article: Dr Niran Rehill is seconded to NIHR Applied Research Collaboration North Thames. This paper presents independent research supported by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.